Antioxidant Mechanism and Protection of Nigral Neurons Against MPP+ Toxicity by Deprenyl (Selegiline)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (50)
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
1983 • 4,822 citations
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
1983 • 2,149 citations
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
1979 • 1,356 citations
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
1984 • 1,092 citations
Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.
1978 • 1,073 citations
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
1989 • 913 citations
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
1989 • 621 citations
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
1992 • 457 citations
Increased life expectancy resulting from addition of l-deprenyl to Madopar� treatment in Parkinson's disease: A longterm study
1985 • 437 citations
Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement
1992 • 371 citations
1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
1990 • 323 citations
IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE
1977 • 293 citations
(−) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats
1991 • 258 citations
Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: Effects of MPP+
1992 • 234 citations
Deprenyl suppresses the oxidant stress associated with increased dopamine turnover
1989 • 210 citations
In Vivo Lipid Peroxidation in Rat Brain Following Intracortical Fe2+ Injection
1984 • 182 citations
Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
1993 • 177 citations
Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo
1993 • 144 citations
Maintenance on l-deprenyl prolongs life in aged male rats
1990 • 138 citations
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B
1990 • 129 citations
Deprenyl in the Treatment of Symptom Fluctuations in Advanced Parkinsonʼs Disease
1988 • 127 citations
CURRENT CONCEPTS CONCERNING RADIOPROTECTIVE AND CRYOPROTECTIVE PROPERTIES OF DIMETHYL SULFOXIDE IN CELLULAR SYSTEMS*
1975 • 123 citations
Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders
1992 • 117 citations
Ferrous‐Citrate Complex and Nigral Degeneration: Evidence for Free‐radical Formation and Lipid Peroxidationa
1994 • 115 citations
The pharmacology of selegiline ((−)deprenyl). New aspects
1989 • 110 citations
Deprenyl Protects Dopamine Neurons from the Neurotoxic Effect of 1‐Methyl‐4‐Phenylpyridinium Ion
1985 • 109 citations
In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+
1992 • 106 citations
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
1987 • 103 citations
TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B
1981 • 103 citations
The molecular pharmacology of L-deprenyl
1992 • 95 citations
Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease
1992 • 92 citations
Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+
1988 • 82 citations
Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicity
1987 • 74 citations
Enhanced hydroxyl radical generation by 2′‐methyl analog of MPTP: Suppression by clorgyline and deprenyl
1992 • 64 citations
Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress
1989 • 58 citations
Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species
1987 • 55 citations
Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity
1994 • 48 citations
(-)Deprenyl-Medication: A Strategy To Modulate the Age-Related Decline of the Striatal Dopaminergic System
1992 • 46 citations
(?)-Deprenyl can induce soluble superoxide dismutase in rat striata
1991 • 38 citations
Hydroxyl Free Radical (·OH) Formation Reflected by Salicylate Hydroxylation and Neuromelanin
1993 • 35 citations
Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates
1987 • 35 citations
Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation invivo in vitamin E deficient mice
1990 • 32 citations
Clinical Advances in Monoamine Oxidase Inhibitor Therapies
1996 • 30 citations
Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum
1993 • 28 citations
Dopamine in the Extrapyramidal Motor Function A Study Based upon the MPTP‐Induced Primate Model of Parkinsonism”a
1988 • 25 citations
(−)Deprenyl and (−)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin
1992 • 23 citations
MPP+ Enhances Potassium‐Evoked Striatal Dopamine Release through a ω‐ConOtoxin‐Insensitive, Tetrodotoxin‐ and Nimodipine‐ Sensitive Calcium‐Dependent Mechanism
1991 • 22 citations
Neurotoxins and Monoamine Oxidase B Inhibitors: Possible Mechanisms for the Neuroprotective Effect of (—)-Deprenyl
1993 • 13 citations
An electrochemical study of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its oxidation products
1988 • 10 citations
Effect of 1-deprenyl on lipid peroxidation in rat brain homogenate
1990 • 4 citations